Actively Recruiting
Study of TEOSYAL RHA 1 for Treating Moderate to Severe Tissue Volume Loss in the Infraorbital Area of Chinese Adults
Led by Teoxane SA · Updated on 2025-01-28
260
Participants Needed
1
Research Sites
43 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating TEOSYAL RHA4 1, a device made of Hyaluronic Acid gel, for correcting moderate to severe tissue volume loss in the infraorbital region under the eyes in Chinese adults. This prospective, multi-center, randomized trial compares TEOSYAL RHA4 1 treatment against no treatment to see if it improves infraorbital hollows. The study is designed to assess the safety and effectiveness of the product with evaluator blinding. Participants will be randomly assigned in a 31 ratio to receive either TEOSYAL RHA4 1 injections in both infraorbital hollows or no treatment. Treated subjects get the injection on Day 0 and may receive touch-up treatment if needed. They will have follow-up visits at 2, 4, 12, 24, 36, and 52 weeks after the last treatment for monitoring. Control group participants will have visits at 2, 4, and 12 weeks after randomization with no treatment given. During the study, all participants will undergo assessments of safety and effectiveness using the Teoxane Infraorbital Hollows Scale TIOHS at various time points, focusing on changes 12 weeks after treatment or randomization. Treated subjects will also receive safety phone calls 3 days post-treatment and after any touch-up. The study concludes after the last follow-up visits, with a total participation period of up to 52 weeks for treated subjects and 12 weeks for controls.
CONDITIONS
Brief Title
TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults
Research Team
E
Elise Gondard
S
Sophie Delhomme
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here